BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 24686772)

  • 21. Diagnosis of prostate cancer in patients with persistently elevated PSA and tumor-negative biopsy in ambulatory care: performance of MR imaging in a multi-reader environment.
    Scheidler J; Weöres I; Brinkschmidt C; Zeitler H; Panzer S; Scharf M; Heuck A; Siebels M
    Rofo; 2012 Feb; 184(2):130-5. PubMed ID: 22274854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A role of multifactorial evaluation of prostatic 3T MRI in patients with elevated prostatic-specific antigen levels: prospective comparison with ultrasound-guided transrectal biopsy.
    Ferda J; Kastner J; Hora M; Hes O; Fínek J; Topolčan O; Kreuzberg B
    Anticancer Res; 2013 Jun; 33(6):2791-5. PubMed ID: 23749943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy.
    Marks LS; Fradet Y; Deras IL; Blase A; Mathis J; Aubin SM; Cancio AT; Desaulniers M; Ellis WJ; Rittenhouse H; Groskopf J
    Urology; 2007 Mar; 69(3):532-5. PubMed ID: 17382159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PSGR and PCA3 as biomarkers for the detection of prostate cancer in urine.
    Rigau M; Morote J; Mir MC; Ballesteros C; Ortega I; Sanchez A; Colás E; Garcia M; Ruiz A; Abal M; Planas J; Reventós J; Doll A
    Prostate; 2010 Dec; 70(16):1760-7. PubMed ID: 20672322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A performance analysis of the presence of malignant circulating prostate cells as a predictive factor for the detection of prostate cancer in the first, second and third prostate biopsy.
    Murray NP; Reyes E; Tapia P; Badinez L; Orellana N; Fuentealba C; Olivares R; Dueñas R
    Arch Esp Urol; 2013 May; 66(4):335-41. PubMed ID: 23676536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a voided urine assay for detecting prostate cancer non-invasively: a pilot study.
    Trabulsi EJ; Tripathi SK; Gomella L; Solomides C; Wickstrom E; Thakur ML
    BJU Int; 2017 Jun; 119(6):885-895. PubMed ID: 28075510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low risk patients benefit from extreme anterior apical sampling on initial biopsy for prostate cancer diagnosis.
    Elshafei A; Kartha G; Li Y; S Moussa A; Hatem A; Gao T; Jones JS
    Prostate; 2014 Sep; 74(12):1183-8. PubMed ID: 24962004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Repeat prostate biopsies following a first negative biopsy in a context of an elevated prostate specific antigen].
    Floc'h AP; Benmeziani R; Delpech PO; Doré B; Fromont G; Irani J
    Prog Urol; 2012 Oct; 22(12):718-24. PubMed ID: 22999119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic performance of malignant prostatic cells detection in blood for early detection of prostate cancer: comparison to prostatic biopsy.
    Murray NP; Reyes E; Tapia P; Orellana N; Dueñas R; Fuentealba C; Badinez L
    Arch Esp Urol; 2011 Dec; 64(10):961-71. PubMed ID: 22228894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prostate cancer and dogs sense of smell: opportunities of noninvasive diagnostics].
    Protoshhak VV; Andreev EA; Karpushhenko EG; Slepcov AV; Ovchinnikov DV; Alentev SA; Lazutkin MV; Mamaenko AV; Mamaenko TV
    Urologiia; 2019 Dec; (5):22-26. PubMed ID: 31808627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunocytochemical study of urine cytological preparations from secondary prostatic adenocarcinoma involving the urinary bladder.
    Mai KT; Ahmed I; Robertson SJ; Belanger EC; Veinot JP; Islam S
    Diagn Cytopathol; 2008 Oct; 36(10):715-20. PubMed ID: 18773445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DD3PCA3 RNA analysis in urine--a new perspective for detecting prostate cancer.
    Tinzl M; Marberger M; Horvath S; Chypre C
    Eur Urol; 2004 Aug; 46(2):182-6; discussion 187. PubMed ID: 15245811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel algorithm for the prediction of prostate cancer in clinically suspected patients.
    Gallotta A; Ziglioli F; Ferretti S; Maestroni U; Moretti M; Aloe R; Gnocchi C; Di Palo M; Fassina G
    Cancer Biomark; 2013; 13(4):227-34. PubMed ID: 24240583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [DiaPat urine test for prostate cancer. Predictive value for results of transrectal ultrasound-guided prostate biopsies].
    Oberpenning F; von Knobloch R; Sprute W; Roth S; Rathert M; Bierer S; Gerss J; Semjonow A
    Urologe A; 2008 Jun; 47(6):735-9. PubMed ID: 18496663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PCA3: a molecular urine assay for predicting prostate biopsy outcome.
    Deras IL; Aubin SM; Blase A; Day JR; Koo S; Partin AW; Ellis WJ; Marks LS; Fradet Y; Rittenhouse H; Groskopf J
    J Urol; 2008 Apr; 179(4):1587-92. PubMed ID: 18295257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of prostate cancer using a voltammetric electronic tongue.
    Pascual L; Campos I; Vivancos JL; Quintás G; Loras A; Martínez-Bisbal MC; Martínez-Máñez R; Boronat F; Ruiz-Cerdà JL
    Analyst; 2016 Aug; 141(15):4562-7. PubMed ID: 27375181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PCA3 urine mRNA testing for prostate carcinoma: patterns of use by community urologists and assay performance in reference laboratory setting.
    Shappell SB; Fulmer J; Arguello D; Wright BS; Oppenheimer JR; Putzi MJ
    Urology; 2009 Feb; 73(2):363-8. PubMed ID: 18995890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathological features of prostate cancer detected on initial and repeat prostate biopsy: results of the prospective European Prostate Cancer Detection study.
    Djavan B; Mazal P; Zlotta A; Wammack R; Ravery V; Remzi M; Susani M; Borkowski A; Hruby S; Boccon-Gibod L; Schulman CC; Marberger M
    Prostate; 2001 May; 47(2):111-7. PubMed ID: 11340633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Positive predictive value of high-grade prostatic intraepithelial neoplasia in initial core needle biopsies of prostate adenocarcinoma--a study with complete sampling of hemi-prostates with corresponding negative biopsy findings.
    Delatour NL; Mai KT
    Urology; 2008 Sep; 72(3):623-7. PubMed ID: 18279923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiparametric magnetic resonance imaging of the prostate can improve the predictive value of the urinary prostate cancer antigen 3 test in patients with elevated prostate-specific antigen levels and a previous negative biopsy.
    Sciarra A; Panebianco V; Cattarino S; Busetto GM; De Berardinis E; Ciccariello M; Gentile V; Salciccia S
    BJU Int; 2012 Dec; 110(11):1661-5. PubMed ID: 22564540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.